Full Press Release Details
The first and only All-in-one subscription platform offering all of your PR Distribution and Media Outreach Tools in one single solution. Monthly & Annual Subscriptions.
Find & create journalist lists with the most up to date database in the industry.
Personalize and customize your pitch for maximum engagement.
Discover your brand, industry, and competitor mentions.
Now you can track every mention, every conversation, and every shift in sentiment — all from the platform you're already using.
Turn your PR data into actionable intelligence with comprehensive reporting and analytics on every campaign.
Catch issues before our editors do. ACCESS Verified gives you a real-time first pass on your press release so you can submit with confidence — every time.
The first and only All-in-one subscription platform that offers you the ability to manage all of your IR communications needs from a single source. Explore our IR subscriptions
Explore how you can upgrade your IR Site today.
Ensure your IR Site is accessible for your entire audience.
Experience seamless calls with our dedicated team of domestic operators.
Easily send your releases out with quick turnarounds and no extra fees.
Host your day knowing you've got the most experienced webcast team in the industry.
Provide a secure and confidential reporting channel to protect your organization and employees.
Streamline your PR & IR needs with one platform.
Easily schedule and manage your investor meetings with our comprehensive and easy to use software.
Our PR and IR tools are designed to meet all necessary regulatory requirements, giving you the confidence to communicate effectively and compliantly. Streamline your communications needs today with our one-stop shop offering.
Whether a startup or established brand, we deliver the support, targeted distribution, media outreach, and flexible pricing & payment options needed to amplify your story with confidence.
We simplify the process of delivering success for both you and your clients. We understand the importance of getting it right, equipping you with seamless billing, flexible plans and payment structures, and clear reporting and analytics to ensure every campaign runs smoothly and achieves measurable results.
We understand the need to manage high volume of press release distribution efficiently. That's why we offer a dedicated API designed specifically for our legal customers, delivering a streamlined, simple process that ensures value and ease at every step.
We understand the importance of cost efficiency for high-volume partners, which is why we offer bulk discounts tailored to meet your needs while maximizing value.
Designed for brands that need help consistently fueling their content strategy and calendar with optimized press releases, blogs, and more…
Tailored for brands with a solid content strategy seeking support for effectively reaching and engaging the media.
Made for brands that need more comprehensive support building and managing their content strategy, media outreach and engagement plan.
Personalized support to optimize your platform, including tailored journalist list creation, pitch guidance, and monitoring setup.
Continual support and management including ongoing list creation, pitch creation and modifications, monitoring adjustments, and additional reporting and analytics review.
Press Release creation and optimization for SEO and audience engagement
Back to the Newsroom cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue Wednesday, 18 November 2026 08:10 AM
Bill introduced by Senators Sheehy and Klobuchar would replace a looming product ban with clear, enforceable federal standards permitting the continued sale of most current lawful hemp-derived products
CHARLOTTE, NC / ACCESS Newswire / November 18, 2026 / cbdMD, Inc. (NYSE American:YCBD), a leading hemp and wellness company, today announced its support for the Hemp Guardrails Act, bipartisan legislation introduced on November 17 by Senators Tim Sheehy (R-MT) and Amy Klobuchar (D-MN). The bill would establish a federal regulatory framework for hemp-derived products and avert the December 11, 2026 implementation of a redefinition that would effectively ban many lawful products nationwide.
"The Hemp Guardrails Act gets this right: it protects consumers without destroying an American industry," said Ronan Kennedy, Chief Executive Officer of cbdMD. "Responsible operators have asked for real rules for years. This bill delivers them, with age-21 sales, child-resistant packaging, third-party testing, FDA manufacturing standards and clear labeling, while preserving the farms, manufacturers and retailers that support an estimated 350,000 American jobs."
Protecting consumers The legislation would:
Protecting jobs and tax revenue Without congressional action, the hemp redefinition taking effect December 11 would remove a broad range of lawful products from the market. Industry estimates put the jobs supported by the hemp sector at approximately 350,000, spanning American farmers, manufacturers, distributors and retailers. The industry also generates substantial tax revenue for states and local communities. The Hemp Guardrails Act would preserve that economic activity while giving regulators the tools to remove bad actors.
"A ban doesn't make anyone safer. It pushes consumers toward unregulated products and costs Americans their jobs," Kennedy added. "We urge Congress to include the Hemp Guardrails Act in the year-end funding package before December 11."
A diversified platform built for regulatory change cbdMD's recent acquisition of the Twinlab, Metabolife and Reserveage brands has added an established portfolio of nutritional supplements that does not rely on hemp-derived cannabinoids. Unlike many hemp-focused peers that depend entirely on cannabinoid products, cbdMD now operates a diversified wellness platform that helps de-risk the business against federal and state regulatory change, whatever the outcome in Congress.
"We support smart regulation because it's right for consumers and for the industry. We've also built cbdMD to perform through regulatory change," said Kennedy. "Twinlab gives us scale and diversification across the broader supplement market, and if this legislation passes, it opens a clear federal pathway for hemp-derived dietary supplements that our combined portfolio is well positioned to serve."
cbdMD has long invested in product safety, including third-party testing of its products and published research on its ingredients. The company stands ready to work with lawmakers and FDA on implementation.
cbdMD, Inc. (NYSE American:YCBD) is a wellness company headquartered in Charlotte, North Carolina, whose portfolio spans the fundamentals to the frontier of wellness. The Company's brands include Twinlab, Reserveage, Metabolife, ResVitale, cbdMD, Paw CBD, Oasis and Bluebird Botanicals, offered through retail, wholesale and direct-to-consumer channels. Guided by the promise of More Life in Every Day, cbdMD is committed to quality, transparency and innovation. To learn more, visit www.cbdmd.com .
This press release contains statements, estimates, forecasts, and projections regarding future performance and events that constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. Those statements include statements regarding expectations from the proposed bill, the probability of the passing of the bill or the passing of the bill in its current form, integration of the Twinlab assets, revenue growth, potential efficiencies resulting from the acquisition and new product offerings. These statements may be identified by the use of words like "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "will," "should," and "seek," and similar expressions set forth herein. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those projected in the forward-looking statements. Important factors and risks that could cause actual results to differ materially from our expectations include, but are not limited to, the successful passing of the bill in its current form and continued regulatory compliance , as well as those risks detailed in our filings with the SEC, including our most recent Form 10-K and other filings with the SEC. The Company undertakes no obligation to update any forward-looking statement, except as required by law.